It is ‘Paxrovid’, an edible treatment for Corona 19, which will arrive in Korea as early as next month.
It is also called a ‘game changer’ because it is easy to use compared to existing injectables.
We have summarized related questions and cautions.
First of all, the target of administration is adults in high-risk groups such as the elderly or those with underlying diseases among corona19 confirmed patients.
Adolescents must be over 12 years old and weigh more than 40 kg to take it.
It can be administered to pregnant women, but it is recommended to only administer it when the risk of gastritis is high and to stop breastfeeding.
It is also not recommended for patients with severe liver or kidney disorders.
Pax Lovid is a single dose of two pink tablets and one white tablet.
If you take it twice a day at 12 hour intervals for 5 days, you are taking 30 tablets for 5 days.
It should be administered as soon as possible within 5 days of a positive diagnosis of COVID-19 and the onset of symptoms.
I’m also interested in how much it costs.
The Ministry of Food and Drug Safety did not disclose the domestic purchase price of Pax Lovid according to the contract, but the contract amount from the US government was about $530 per person, or about 630,000 won in Korean money, and there is no burden on the patient in Korea.
We also looked at what could be the adverse reactions that we are concerned about.
According to the Ministry of Food and Drug Safety, in clinical trials, diarrhea, nausea, and abnormal taste appeared, and most of the symptoms were mild.
In addition, when patients with arrhythmia, hyperlipidemia, or gout take Paxrovid, they need to temporarily stop taking the drug, which requires consultation with a medical professional.
Finally, if side effects occur, you can also apply for compensation for damage.
If a patient, guardian, or medical staff submits the relevant information in writing or online to the Korea Drug Safety Management Agency, it will be reviewed and if causality is recognized, damage may be compensated.
YTN Choi Doo-hee ([email protected])
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]